{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:17:09Z","timestamp":1792707429795,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":36,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asia-Pacific Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.apjo.2024.100108","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T13:28:15Z","timestamp":1728566895000},"page":"100108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Gain of chromosome 8q and high expression of EZH2 may predict poor prognosis in Chinese patients with uveal melanoma"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5460-8679","authenticated-orcid":false,"given":"Lingyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongxin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiwei","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renbing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9394-3969","authenticated-orcid":false,"given":"Xianqun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apjo.2024.100108_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.apjo.2024.100108_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes","volume":"127","author":"Shields","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100108_bib3","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma","volume":"44","author":"Kujala","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.apjo.2024.100108_bib4","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/annonc\/mdt585","article-title":"Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial","volume":"25","author":"Leyvraz","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.apjo.2024.100108_bib5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/bjc.2016.419","article-title":"Phase II randomised discontinuation trial of the MET\/VEGF receptor inhibitor cabozantinib in metastatic melanoma","volume":"116","author":"Daud","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.apjo.2024.100108_bib6","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1200\/JCO.2017.74.1090","article-title":"Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)","volume":"36","author":"Carvajal","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apjo.2024.100108_bib7","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJMoa2103485","article-title":"Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma","volume":"385","author":"Nathan","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apjo.2024.100108_bib8","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/IAE.0b013e31824d09a8","article-title":"Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases","volume":"32","author":"Shields","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.apjo.2024.100108_bib9","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.ophtha.2008.04.025","article-title":"Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability","volume":"115","author":"Coupland","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100108_bib10","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.ophtha.2007.06.012","article-title":"Cytogenetics of uveal melanoma: a 7-year clinical experience","volume":"114","author":"Damato","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100108_bib11","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1097\/00008390-200609001-00088","article-title":"Revisiting the value of assessing the mitotic rate of choroidal melanomas","volume":"16","author":"Coupland","year":"2006","journal-title":"Melanoma Res"},{"key":"10.1016\/j.apjo.2024.100108_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/jnci\/91.4.359","article-title":"Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas","volume":"91","author":"M\u00e4kitie","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.apjo.2024.100108_bib13","first-page":"1414","article-title":"Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma","volume":"42","author":"M\u00e4kitie","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.apjo.2024.100108_bib14","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1167\/iovs.02-0159","article-title":"Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival","volume":"44","author":"Scholes","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.apjo.2024.100108_bib15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1167\/iovs.16-20212","article-title":"The Prognostic Value of AJCC Staging in Uveal Melanoma Is Enhanced by Adding Chromosome 3 and 8q Status","volume":"58","author":"Dogrus\u00f6z","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.apjo.2024.100108_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ophtha.2021.11.011","article-title":"Chromosome 3 and 8q Aberrations in Uveal Melanoma Show Greater Impact on Survival in Patients with Light Iris versus Dark Iris Color","volume":"129","author":"Wierenga","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100108_bib17","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ajo.2005.05.034","article-title":"Population-Based Incidence of Uveal Melanoma in Various Races and Ethnic Groups","volume":"140","author":"Hu","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100108_bib18","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ophtha.2016.01.023","article-title":"Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases","volume":"123","author":"Yavuzyigitoglu","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100108_bib19","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-38862-1","article-title":"BAP1: Not just a BRCA1-associated protein","volume":"90","author":"Louie","year":"2020","journal-title":"Cancer Trea Rev"},{"key":"10.1016\/j.apjo.2024.100108_bib20","first-page":"855","article-title":"Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor\/scatter factor (HGF\/SF)","volume":"152","author":"Hendrix","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apjo.2024.100108_bib21","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s41588-019-0440-9","article-title":"The genetic evolution of metastatic uveal melanoma","volume":"51","author":"Shain","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.apjo.2024.100108_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-020-01173-x","article-title":"Verification of EZH2 as a druggable target in metastatic uveal melanoma","volume":"19","author":"Jin","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apjo.2024.100108_bib23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nm.4098","article-title":"Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status","volume":"22","author":"Schoumacher","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.apjo.2024.100108_bib24","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.humpath.2011.12.004","article-title":"Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer","volume":"43","author":"Hussein","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.apjo.2024.100108_bib25","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1158\/1078-0432.CCR-19-1215","article-title":"Evolutionary Routes in Metastatic Uveal Melanomas Depend on MBD4 Alterations","volume":"25","author":"Rodrigues","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apjo.2024.100108_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.101030","article-title":"Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma","volume":"89","author":"Chai","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.apjo.2024.100108_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.apjo.2024.100108_bib28","first-page":"186","article-title":"Uveal Melanoma Treatment and Prognostication. Asia Pac","volume":"6","author":"Dogrus\u00f6z","year":"2017","journal-title":"J Ophthalmol (Philos)"},{"key":"10.1016\/j.apjo.2024.100108_bib29","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/archopht.123.12.1639","article-title":"Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26","volume":"123","author":"Diener-West","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100108_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajo.2009.01.023","article-title":"Effectiveness of treatments for metastatic uveal melanoma","volume":"148","author":"Augsburger","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100108_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1167\/iovs.61.3.31","article-title":"Prognostic Factors Five Years After Enucleation for Uveal Melanoma","volume":"61","author":"Dogrus\u00f6z","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.apjo.2024.100108_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/09286580600977281","article-title":"Survival from uveal melanoma in England and Wales 1986 to 2001","volume":"14","author":"Burr","year":"2007","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.apjo.2024.100108_bib33","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0161-6420(03)00077-0","article-title":"Survival rates with uveal melanoma in the United States: 1973-1997","volume":"110","author":"Singh","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100108_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144562","article-title":"Clinical Characteristics of 582 Patients with Uveal Melanoma in China","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.apjo.2024.100108_bib35","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/02713683.2016.1245422","article-title":"Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up","volume":"42","author":"Yue","year":"2017","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.apjo.2024.100108_bib36","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1007\/s10792-020-01494-2","article-title":"Posterior uveal melanoma in 321 Asian Indian patients: analysis based on the 8th edition of American Joint Committee Cancer classification","volume":"40","author":"Kapoor","year":"2020","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100108_bib37","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/bjophthalmol-2012-302584","article-title":"Prognosis of choroidal melanoma and the result of ruthenium brachytherapy combined with transpupillary thermotherapy in Korean patients","volume":"97","author":"Kwon","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100108_bib38","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/eye.2015.51","article-title":"Prognosis of uveal melanoma based on race in 8100 patients: The 2015 Doyne Lecture","volume":"29","author":"Shields","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.apjo.2024.100108_bib39","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apjo.2024.100108_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100297","article-title":"Increased Histological Tumor Pigmentation in Uveal Melanoma Is Related to Eye Color and Loss of Chromosome 3\/BAP1","volume":"3","author":"Gelmi","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.apjo.2024.100108_bib41","article-title":"Impact of iris color on uveal melanoma-related outcomes in 7245 patients at a single ocular oncology center","volume":"13","author":"Zaloga","year":"2024","journal-title":"Asia Pac J Ophthalmol (Philos)"},{"key":"10.1016\/j.apjo.2024.100108_bib42","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/archopht.117.6.811","article-title":"Iris color as a prognostic factor in ocular melanoma","volume":"117","author":"Regan","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100108_bib43","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0002-9394(98)00040-3","article-title":"Histopathologic characteristics of uveal melanomas in eyes enucleated from the Collaborative Ocular Melanoma Study. COMS report no. 6","volume":"125","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100108_bib44","first-page":"2153","article-title":"Association of HLA class I and class II antigen expression and mortality in uveal melanoma","volume":"42","author":"Ericsson","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.apjo.2024.100108_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114419","article-title":"Targeting EZH2 for cancer therapy: From current progress to novel strategies","volume":"238","author":"Zeng","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apjo.2024.100108_bib46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.eururo.2006.11.020","article-title":"Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features","volume":"52","author":"van Leenders","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.apjo.2024.100108_bib47","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.biopha.2015.07.038","article-title":"Clinical and prognostic relevance of EZH2 in breast cancer: A meta-analysis","volume":"75","author":"Wang","year":"2015","journal-title":"Biomed Pharm"},{"key":"10.1016\/j.apjo.2024.100108_bib48","doi-asserted-by":"crossref","first-page":"76423","DOI":"10.18632\/oncotarget.19462","article-title":"Expression of EZH2 in uveal melanomas patients and associations with prognosis","volume":"8","author":"Cheng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.apjo.2024.100108_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1013475","article-title":"EZH2-mediated H3K27me3 is a predictive biomarker and therapeutic target in uveal melanoma","volume":"13","author":"Hou","year":"2022","journal-title":"Front Genet"}],"container-title":["Asia-Pacific Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162098924001191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162098924001191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T08:39:19Z","timestamp":1729759159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162098924001191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2162098924001191"],"URL":"https:\/\/doi.org\/10.1016\/j.apjo.2024.100108","relation":{},"ISSN":["2162-0989"],"issn-type":[{"value":"2162-0989","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gain of chromosome 8q and high expression of EZH2 may predict poor prognosis in Chinese patients with uveal melanoma","name":"articletitle","label":"Article Title"},{"value":"Asia-Pacific Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apjo.2024.100108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of Asia-Pacific Academy of Ophthalmology and Academy of Asia-Pacific Professors of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100108"}}